backJoin us for the thirteenth CLE webinar in our Fundamentals of EU Pharmaceutical Law series.
Following the recent publication of the negotiated final texts of the Revision, we will take a deeper dive into the Key Revisions of the EU General Pharmaceutical Legislation. This webinar will provide a detailed analysis of the adopted provisions, with particular focus on how the revised framework may support innovation.
The session will examine the rules especially designed to boost innovation, such as those enhancing regulatory flexibility, regulatory exclusivities and incentive mechanisms, as well as the new provisions affecting emerging categories of products and technologies.
We will also discuss the rules that may raise challenges for innovators and the strategic planning that the new obligations on marketing authorization holders may impose on pharmaceutical companies operating or planning to operate in Europe.
This webinar will provide participants with practical insights into how the revised EU pharmaceutical framework seeks to balance innovation, public health objectives and the protection of industry interests — a balance that increasingly shapes regulatory strategy and risk management in the EU.
For questions or to register, contact Sydney Forte.